Sesti G, Bardtrum L, Dagdelen S, Halladin N, et al. A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice. Diabetes Obes Metab 2020 Jan 5. doi: 10.1111/dom.13957.
PMID: 31903724